▁Chron 9.2890625
ic 0.54736328125
▁pain 2.765625
▁is 1.1640625
▁still 6.71875
▁considered 3.990234375
▁to 1.9228515625
▁be 0.03277587890625
▁an 2.6796875
▁extr 10.859375
E 17.53125
me 2.10546875
▁issue 4.8671875
▁among 3.783203125
▁at 9.3828125
▁least 0.779296875
▁ 0.642578125
8 3.265625
% 2.4140625
▁of 0.141845703125
▁the 0.452880859375
▁residents 7.375
▁of 0.5302734375
▁progress 11.9453125
ive 0.1607666015625
▁countries 1.298828125
. 0.76220703125
▁The 2.28125
▁introduction 7.22265625
▁of 0.047515869140625
▁the 2.271484375
▁study 7.4921875
▁describes 7.49609375
▁the 0.464599609375
▁apparent 9.5390625
▁link 5.51171875
▁between 0.15966796875
▁pain 2.57421875
▁and 0.2435302734375
▁dem 6.83203125
oral 4.46875
ization 0.1256103515625
. 1.3017578125
▁Chron 3.77734375
ic 0.00411224365234375
▁pain 0.1092529296875
▁is 1.0361328125
▁Always 14.2890625
▁accompanied 3.115234375
▁by 0.07684326171875
▁negative 4.375
▁emot 0.84130859375
ional 1.5517578125
▁experiences 2.810546875
▁and 2.09375
▁blocks 10.71875
▁a 3.61328125
▁person 0.66162109375
’ 0.8505859375
s 0.001796722412109375
▁ability 1.2978515625
▁to 0.02960205078125
▁receive 6.7421875
▁joy 3.84765625
▁and 1.2978515625
▁satisfaction 3.109375
▁from 0.888671875
▁life 0.66748046875
. 0.270263671875
▁The 1.87890625
▁research 3.431640625
▁investig 6.13671875
ates 0.552734375
▁the 0.324951171875
▁development 6.38671875
▁of 0.157470703125
▁de 3.9921875
pression 0.431396484375
▁and 1.36328125
▁anx 1.712890625
iety 0.001003265380859375
▁among 1.728515625
▁patients 1.25
▁Rece 10.5078125
iving 0.020599365234375
▁ph 5.70703125
arma 3.05859375
ce 0.0179443359375
ut 0.002033233642578125
ical 0.003391265869140625
▁op 4.69140625
io 0.14013671875
ids 0.457763671875
▁and 2.52734375
▁medical 3.900390625
▁mar 2.029296875
iju 0.00441741943359375
ana 0.0003466606140136719
▁( 2.923828125
MM 1.1630859375
) 2.4609375
▁as 2.685546875
▁severe 10.3515625
▁p 5.67578125
A 4.03515625
ink 11.0078125
ill 6.953125
ers 0.04052734375
. 0.38720703125
▁It 3.318359375
▁comp 5.41796875
ares 0.0153350830078125
▁the 0.60400390625
▁eff 8.2734375
i 2.822265625
C 0.164306640625
acy 0.3642578125
▁of 0.19482421875
▁pres 6.31640625
cri 2.09765625
ptions 1.7001953125
▁and 2.1171875
▁exam 5.11328125
ines 0.02410888671875
▁the 0.428466796875
▁possibility 3.544921875
▁of 0.09954833984375
▁post 8.3125
- 0.8896484375
tre 1.6884765625
at 0.00860595703125
ment 0.0098724365234375
▁de 1.7177734375
pression 0.09051513671875
. 1.4267578125
<0x0A> 1.1767578125
There 4.984375
▁is 1.345703125
▁currently 4.890625
▁a 1.2900390625
▁severe 5.1953125
▁lack 1.888671875
▁of 0.0183258056640625
▁information 2.234375
▁about 1.0615234375
▁the 0.44091796875
▁effects 2.966796875
▁of 0.0694580078125
▁op 2.640625
i 3.078125
ates 0.1070556640625
. 3.203125
▁They 4.734375
▁manage 8.5546875
▁pain 2.970703125
▁successfully 6.828125
, 0.9072265625
▁but 0.230712890625
▁the 2.685546875
▁past 8.890625
▁few 2.04296875
▁dec 1.4208984375
ades 0.005859375
▁indicated 8.578125
▁the 1.892578125
▁growing 4.0
▁concern 3.88671875
▁regarding 3.505859375
▁op 2.568359375
iate 1.2099609375
▁ab 1.638671875
use 0.0157318115234375
▁in 3.75390625
▁forms 9.4765625
▁of 0.461669921875
▁over 3.443359375
d 0.11090087890625
ose 0.27880859375
▁and 0.734375
▁add 0.80810546875
iction 0.0186920166015625
. 0.14794921875
▁A 3.98046875
▁more 4.8671875
▁manage 8.1875
able 0.0028171539306640625
▁and 2.05078125
▁sa 1.97265625
fer 0.005096435546875
▁alternative 1.314453125
▁might 5.171875
▁be 0.1251220703125
▁medical 1.5234375
▁mar 0.1817626953125
iju 0.00701141357421875
ana 0.0013332366943359375
. 0.93505859375
▁However 3.62890625
, 0.00919342041015625
▁the 1.7880859375
▁legal 3.998046875
▁status 1.158203125
▁and 2.9921875
▁novel 9.9609375
ty 0.14697265625
▁of 0.1519775390625
▁this 2.193359375
▁drug 1.611328125
▁do 4.51953125
▁not 0.020477294921875
▁allow 0.7041015625
▁finding 7.33984375
▁a 2.400390625
▁large 2.513671875
▁number 0.77734375
▁of 0.004787445068359375
▁studies 1.1552734375
▁on 1.7431640625
▁its 0.79345703125
▁effect 2.390625
iveness 0.276611328125
. 0.61376953125
▁Spe 9.8984375
ci 3.310546875
F 1.0322265625
ically 0.58837890625
, 0.108642578125
▁it 2.810546875
▁concerns 4.58203125
▁the 0.8857421875
▁emot 7.06640625
ional 0.02752685546875
▁condition 4.70703125
▁of 0.2489013671875
▁patients 0.65087890625
▁experien 5.57421875
cing 0.004337310791015625
▁chron 0.8046875
ic 0.0051727294921875
▁pain 0.306640625
. 0.454345703125
▁This 2.89453125
▁research 1.919921875
▁paper 4.09765625
▁a 1.9716796875
ims 0.001049041748046875
▁to 0.10321044921875
▁analyze 3.373046875
▁levels 9.78125
▁of 0.0225830078125
▁de 0.499755859375
pression 0.022003173828125
▁and 0.1964111328125
▁anx 0.0256805419921875
iety 0.0023975372314453125
▁among 0.6982421875
▁people 2.73828125
▁receiving 1.9296875
▁ther 6.32421875
apy 0.0706787109375
▁by 4.40234375
▁comparing 8.609375
▁the 1.49609375
▁effects 2.01171875
▁of 0.0299835205078125
▁ph 2.759765625
arma 0.043670654296875
ce 0.006252288818359375
ut 0.001079559326171875
ical 0.0048675537109375
▁op 0.12469482421875
io 0.6904296875
ids 0.033477783203125
▁and 0.2470703125
▁MM 0.728515625
. 0.271484375
<0x0A> 0.53173828125
The 0.86767578125
▁study 1.6953125
▁was 2.0859375
▁conducted 0.58642578125
▁in 1.1533203125
▁the 1.3935546875
▁form 2.830078125
▁of 0.003787994384765625
▁collection 11.546875
▁and 0.779296875
▁analysis 0.379638671875
▁of 0.0163116455078125
▁statistical 3.8046875
▁data 0.152099609375
. 0.98291015625
▁Part 5.10546875
icip 0.143310546875
ants 0.08734130859375
▁were 0.703125
▁rec 3.5234375
ru 0.0023479461669921875
ited 0.0004241466522216797
▁for 4.125
▁six 6.83203125
▁months 0.348876953125
▁at 3.814453125
▁two 2.646484375
▁major 4.28515625
▁pain 2.796875
▁relief 4.5546875
▁cent 0.68212890625
ers 0.061737060546875
▁in 0.6455078125
▁Israel 5.0234375
. 0.348388671875
▁The 1.255859375
▁research 2.537109375
ers 1.4111328125
▁used 2.134765625
▁The 6.43359375
▁De 3.1171875
pression 0.051361083984375
▁Module 6.85546875
▁of 0.73046875
▁the 0.3046875
▁Pat 3.20703125
ient 0.01861572265625
▁Health 0.06671142578125
▁Question 0.0278167724609375
naire 0.03106689453125
▁and 2.677734375
▁the 0.6376953125
▁General 1.1650390625
ized 0.48095703125
▁An 0.0170135498046875
x 0.0029430389404296875
iety 0.0030956268310546875
▁Dis 0.157470703125
order 0.03607177734375
▁Sc 1.265625
ale 0.00424957275390625
▁to 0.9619140625
▁interview 7.921875
▁participants 2.552734375
, 4.24609375
▁evaluate 4.89453125
▁their 0.5849609375
▁answers 3.998046875
, 0.375244140625
▁and 0.039398193359375
▁conduct 5.03515625
▁the 1.8408203125
▁study 2.462890625
. 0.09637451171875
▁To 4.73828125
▁specifically 10.3359375
▁evaluate 2.98046875
▁and 5.1640625
▁compare 0.5615234375
▁the 0.355224609375
▁prob 9.6328125
abilities 0.1973876953125
▁of 0.07855224609375
▁de 0.92138671875
press 3.654296875
I 6.4765625
on 0.0855712890625
▁or 4.18359375
▁anx 0.07012939453125
iety 0.08575439453125
▁among 1.4658203125
▁the 1.96875
▁diverse 9.8671875
▁groups 0.82470703125
, 0.7841796875
▁the 0.486083984375
▁study 2.802734375
▁used 1.2958984375
▁multiple 5.515625
▁log 0.537109375
istic 0.09661865234375
▁regression 0.320556640625
▁analysis 1.3046875
▁and 2.798828125
▁chose 8.3359375
▁medical 6.56640625
▁mar 0.12127685546875
iju 0.015838623046875
ana 0.0012073516845703125
▁as 0.5380859375
▁the 0.8681640625
▁control 2.958984375
▁group 0.61376953125
. 0.284423828125
<0x0A> 0.5087890625
This 3.927734375
▁type 5.96484375
▁of 0.0041351318359375
▁study 1.45703125
▁is 1.447265625
▁the 3.65234375
▁most 1.0966796875
▁reve 8.3828125
aling 0.007251739501953125
▁and 1.52734375
▁inclus 6.92578125
ive 0.0093231201171875
, 2.857421875
▁as 1.3095703125
▁it 0.302001953125
▁contains 4.83203125
▁direct 6.3125
▁responses 5.52734375
▁from 0.568359375
▁a 3.443359375
▁large 0.89990234375
▁number 0.47021484375
▁of 0.005458831787109375
▁participants 0.99951171875
. 0.66357421875
▁All 5.49609375
▁tools 8.21875
▁in 5.5546875
▁the 0.79638671875
▁form 4.53515625
▁of 0.02764892578125
▁question 0.654296875
na 0.014434814453125
ires 0.0038852691650390625
▁an 9.5234375
D 0.7568359375
▁scales 3.158203125
▁have 3.287109375
▁already 3.888671875
▁been 0.34130859375
▁used 2.40625
▁and 1.6953125
▁proved 2.486328125
▁their 1.1748046875
▁effic 2.599609375
acy 0.05877685546875
▁for 3.677734375
▁collect 4.22265625
ing 0.0063629150390625
▁analyt 7.4765625
ical 0.07855224609375
▁data 0.2088623046875
. 0.38525390625
▁It 3.46484375
▁helps 4.21484375
▁to 0.66650390625
▁system 6.45703125
at 0.266845703125
ize 0.03021240234375
▁and 1.265625
▁class 4.75
ify 0.0199737548828125
▁distinct 8.453125
▁kinds 6.296875
▁of 0.019500732421875
▁information 1.9912109375
▁for 4.07421875
▁subsequent 4.69921875
▁un 8.7109375
comp 5.171875
licated 0.03375244140625
▁services 12.4453125
. 0.5263671875
▁Thus 4.91015625
, 0.01132965087890625
▁research 4.5234375
ers 0.31689453125
▁can 1.6640625
▁compare 2.83984375
▁the 1.0078125
▁effects 2.796875
▁of 0.113525390625
▁medic 3.955078125
ations 0.77880859375
▁on 1.623046875
▁patients 2.166015625
▁of 4.20703125
▁diverse 3.2890625
▁age 2.1796875
▁groups 2.08203125
, 0.7509765625
▁background 4.0
s 0.10723876953125
, 0.0278472900390625
▁physical 5.73046875
▁conditions 1.43359375
, 0.04522705078125
▁emot 6.41015625
ional 0.0655517578125
▁states 1.25
, 0.0477294921875
▁and 0.353759765625
▁so 2.828125
▁on 0.11627197265625
. 0.0802001953125
<0x0A> 0.81689453125
The 0.74951171875
▁analysis 4.0546875
▁of 0.72314453125
▁any 9.4140625
▁human 6.82421875
▁reaction 4.3359375
▁has 4.65625
▁a 1.7744140625
▁high 3.236328125
▁potential 3.048828125
▁of 2.30859375
▁subject 3.03125
iveness 3.759765625
▁and 1.212890625
▁bias 1.9912109375
, 1.8623046875
▁especially 2.5
▁regarding 3.859375
▁people 4.9609375
▁in 3.826171875
▁severe 2.736328125
▁pain 0.5439453125
▁and 2.169921875
▁un 5.48828125
stable 1.3876953125
▁emot 0.60888671875
ional 0.135986328125
▁condition 2.669921875
. 0.05963134765625
▁Perhaps 8.515625
▁some 5.30078125
▁patients 2.203125
▁tend 4.9921875
▁to 0.01250457763671875
▁ex 1.9453125
agger 0.02044677734375
ate 0.0057830810546875
▁their 0.95068359375
▁de 3.2890625
press 1.1376953125
ive 0.4599609375
▁state 2.533203125
▁or 1.638671875
▁vice 5.921875
▁vers 0.03314208984375
a 0.0003514289855957031
, 1.0498046875
▁de 7.3046875
- 1.7744140625
emph 0.330810546875
as 0.00934600830078125
ize 0.08990478515625
▁serious 6.8125
▁difficulties 5.49609375
. 0.87744140625
▁Because 6.171875
▁the 2.78125
▁survey 4.73828125
▁responses 6.88671875
▁were 1.439453125
▁thoroughly 8.6171875
▁anonymous 2.8984375
, 0.298583984375
▁the 1.23828125
▁research 1.0068359375
ers 0.1932373046875
▁were 2.45703125
▁unable 2.916015625
▁to 0.002704620361328125
▁carefully 7.92578125
▁analyze 2.814453125
▁each 2.3828125
▁patient 2.69140625
’ 0.5419921875
s 0.00875091552734375
▁reaction 4.078125
▁and 1.298828125
▁compare 3.619140625
▁it 0.86279296875
▁to 0.66064453125
▁the 1.009765625
▁actual 4.44921875
▁states 7.59765625
▁of 0.7783203125
▁condition 6.95703125
. 0.34912109375
▁More 6.33203125
▁accurate 3.23046875
▁answers 4.171875
▁could 1.7763671875
▁be 0.75732421875
▁obtained 0.98974609375
▁by 1.4365234375
▁professional 6.1328125
▁psych 1.2080078125
olog 0.33251953125
ists 0.00849151611328125
▁via 7.2421875
▁personal 2.63671875
▁communication 4.375
▁and 1.8603515625
▁behavior 6.171875
al 0.29150390625
▁analysis 2.05078125
. 0.270751953125
▁However 2.712890625
, 0.0008630752563476562
▁this 1.4150390625
▁method 2.234375
▁of 2.6171875
▁research 1.892578125
▁is 1.1953125
▁way 6.0
▁more 0.78857421875
▁resource 4.5390625
- 0.265869140625
int 1.15625
ensive 0.0293426513671875
▁and 0.393310546875
▁energy 10.6953125
- 0.07012939453125
consum 0.375732421875
ing 0.0044403076171875
. 0.72412109375
<0x0A> 0.474609375
Part 5.671875
icip 0.173583984375
ants 0.142822265625
▁were 1.3349609375
▁rec 1.9716796875
ru 0.0014390945434570312
ited 0.00017511844635009766
▁for 1.625
▁six 0.294921875
▁months 0.00881195068359375
▁at 0.349365234375
▁two 0.0732421875
▁major 0.09814453125
▁pain 0.039031982421875
▁relief 0.03619384765625
▁cent 0.01242828369140625
ers 0.0025424957275390625
▁in 0.0428466796875
▁Israel 0.02276611328125
. 0.1903076171875
▁All 4.203125
▁patients 1.927734375
▁experienced 4.49609375
▁chron 0.751953125
ic 0.01171112060546875
▁pain 0.291015625
▁for 2.498046875
▁at 0.6416015625
▁least 0.005336761474609375
▁ 1.8603515625
3 1.576171875
▁months 0.32861328125
. 1.2685546875
▁The 1.3671875
▁study 1.7236328125
▁included 1.5478515625
▁ 0.53955078125
8 3.025390625
9 2.521484375
0 2.880859375
▁particip 7.69921875
an 3.01953125
T 0.8408203125
s 0.0265350341796875
, 1.373046875
▁of 2.681640625
▁which 0.5771484375
▁ 0.08856201171875
4 1.25390625
7 2.5703125
4 2.626953125
▁( 2.736328125
5 0.09844970703125
9 5.3046875
%) 0.85009765625
▁were 0.775390625
▁treated 2.953125
▁sole 6.484375
ly 0.0042877197265625
▁with 0.292236328125
▁op 1.150390625
io 0.466796875
ids 0.1351318359375
, 0.51123046875
▁ 0.6689453125
3 1.2744140625
2 2.263671875
9 2.466796875
▁( 0.05426025390625
4 2.49609375
1 1.529296875
%) 0.066650390625
▁were 1.4375
▁treated 0.53271484375
▁with 0.36083984375
▁MM 0.77001953125
, 0.373291015625
▁and 0.09674072265625
▁ 0.22119140625
7 2.134765625
7 2.3984375
▁( 0.10369873046875
8 1.9873046875
. 1.0419921875
6 2.5078125
%) 0.0792236328125
▁acquired 10.4375
▁both 0.6220703125
▁( 4.85546875
Fe 9.390625
ing 1.25
old 0.461181640625
▁et 0.89892578125
▁al 0.02099609375
., 0.1732177734375
▁ 0.015777587890625
2 0.005329132080078125
0 0.0004334449768066406
1 0.54833984375
7 1.7490234375
). 0.038330078125
▁The 1.189453125
▁remaining 7.734375
▁ten 6.64453125
▁participants 1.4716796875
▁who 4.796875
▁did 2.193359375
▁not 0.01035308837890625
▁receive 2.470703125
▁ph 3.771484375
arma 0.09967041015625
ce 0.0027141571044921875
ut 0.0005955696105957031
ical 0.006076812744140625
▁op 1.1328125
io 0.0657958984375
ids 0.02215576171875
▁and 2.4296875
▁medical 1.4931640625
▁mar 0.04547119140625
iju 0.006816864013671875
ana 0.0007829666137695312
▁were 0.447509765625
▁with 6.91015625
dra 0.0740966796875
wn 0.0019168853759765625
▁from 0.255615234375
▁the 0.1612548828125
▁analysis 2.32421875
▁in 5.03125
▁the 1.1103515625
▁research 4.546875
. 1.078125
▁Therefore 5.1171875
, 0.01230621337890625
▁it 3.84765625
▁is 1.412109375
▁n 8.421875
O 1.0595703125
t 0.09521484375
▁possible 0.890625
▁to 0.007755279541015625
▁compreh 6.12109375
ens 0.114013671875
ively 0.01410675048828125
▁compare 1.322265625
▁patients 5.2734375
▁taking 3.9296875
▁medic 4.30078125
ations 0.595703125
▁with 1.55078125
▁those 0.984375
▁who 0.7900390625
▁do 1.3173828125
▁not 0.0153045654296875
. 0.65966796875
<0x0A> 0.6630859375
The 0.8779296875
▁study 1.6826171875
▁conducted 4.41796875
▁a 1.859375
▁correlation 6.515625
▁type 9.6484375
▁of 0.21923828125
▁research 1.00390625
▁with 3.537109375
▁variable 8.5546875
▁measures 5.17578125
. 0.8955078125
▁It 1.3955078125
▁evaluated 4.54296875
▁the 0.61376953125
▁inter 6.29296875
dep 2.623046875
end 0.01361083984375
ence 0.008209228515625
▁of 0.64501953125
▁various 3.390625
▁factors 0.912109375
▁that 2.94140625
▁affected 4.05859375
▁the 0.457275390625
▁physical 6.203125
▁and 0.274169921875
▁emot 0.3935546875
ional 0.0015850067138671875
▁condition 1.4697265625
▁of 0.040863037109375
▁patients 0.84765625
▁experien 2.75
cing 0.003910064697265625
▁chron 0.21484375
ic 0.0183258056640625
▁pain 0.1258544921875
. 0.1365966796875
▁For 4.10546875
▁example 1.029296875
, 0.0020599365234375
▁the 1.0419921875
▁su 11.3515625
R 3.701171875
vey 0.08343505859375
▁showed 4.09765625
▁that 0.360107421875
▁the 1.9453125
▁ratio 6.5859375
▁of 0.0703125
▁female 3.787109375
▁patients 0.99462890625
▁was 1.2490234375
▁remark 8.0625
ably 0.004657745361328125
▁higher 0.2037353515625
▁in 2.49609375
▁the 0.449462890625
▁op 3.970703125
i 2.875
ates 0.171875
▁group 0.2105712890625
▁compared 2.578125
▁to 0.03582763671875
▁the 0.64892578125
▁MM 0.1651611328125
▁group 0.33984375
. 0.6318359375
▁In 3.41015625
▁turn 3.806640625
, 0.0018091201782226562
▁people 4.96484375
▁on 4.73046875
▁op 3.26171875
i 0.7529296875
ates 0.0243377685546875
▁were 0.89111328125
▁more 1.376953125
▁likely 0.27001953125
▁to 0.019073486328125
▁report 2.744140625
▁major 6.05078125
▁de 0.457275390625
press 0.765625
ive 0.12005615234375
▁dis 1.150390625
orders 1.2861328125
. 1.734375
<0x0A> 2.189453125
The 0.89501953125
▁question 5.59375
na 0.826171875
ires 0.022796630859375
▁u 10.15625
S 1.4931640625
ed 0.00443267822265625
▁different 8.0234375
▁variable 8.4765625
▁measures 0.46337890625
▁to 1.369140625
▁collect 2.474609375
▁information 1.65625
. 1.4248046875
▁For 1.57421875
▁example 0.27978515625
, 0.002105712890625
▁it 3.94921875
▁included 1.7998046875
▁compreh 8.5234375
ensive 0.038970947265625
▁so 5.4453125
cio 0.0149688720703125
- 0.34912109375
dem 0.11077880859375
ographic 0.09906005859375
▁data 0.89404296875
: 4.75
▁gender 1.9775390625
, 0.0526123046875
▁age 0.285888671875
, 0.040557861328125
▁country 4.21875
, 2.837890625
▁type 4.4453125
▁of 0.07843017578125
▁residence 3.73046875
▁( 2.478515625
urban 0.82568359375
/ 1.4697265625
r 0.1715087890625
ural 0.00644683837890625
), 0.1748046875
▁years 6.12109375
▁of 0.1785888671875
▁education 0.71533203125
, 0.09307861328125
▁and 1.3271484375
▁employ 2.583984375
ment 0.0024204254150390625
▁status 0.67919921875
. 0.171630859375
▁Pat 4.4765625
ients 0.07843017578125
▁were 1.09765625
▁also 0.7880859375
▁asked 0.451171875
▁about 0.90625
▁their 0.6318359375
▁medical 2.623046875
▁history 0.480224609375
▁over 8.6015625
▁the 0.0616455078125
▁years 4.8046875
▁and 1.6513671875
▁the 1.4912109375
▁current 2.970703125
▁presence 4.98046875
▁of 0.099853515625
▁any 2.20703125
▁severe 3.7421875
▁dise 1.9619140625
ases 0.0019378662109375
▁such 4.3125
▁as 0.0025005340576171875
▁heart 2.56640625
▁failure 1.71484375
, 0.31591796875
▁di 1.568359375
ab 0.004238128662109375
etes 0.002300262451171875
, 0.07012939453125
▁ar 4.08203125
th 0.1055908203125
rit 0.041290283203125
is 0.011993408203125
, 0.02545166015625
▁and 1.16796875
▁so 0.74755859375
▁on 0.04168701171875
. 0.0521240234375
▁The 1.734375
▁third 6.8125
▁measure 3.521484375
▁of 2.505859375
▁the 0.6376953125
▁question 1.8798828125
naire 0.33447265625
▁was 1.02734375
▁indicated 10.578125
▁by 1.19140625
▁info 11.1796875
R 0.5146484375
m 0.0517578125
ation 0.043609619140625
▁on 2.171875
▁any 5.48828125
▁twelve 14.2890625
- 0.17236328125
month 0.13525390625
▁and 4.9375
▁lifetime 0.5693359375
▁drug 3.39453125
▁an 8.078125
D 0.05450439453125
▁alco 0.09576416015625
hol 0.0267333984375
▁consumption 4.4609375
. 0.46484375
▁In 3.58203125
▁addition 0.81982421875
, 0.1636962890625
▁the 0.9677734375
▁record 10.3046875
▁included 1.095703125
▁a 2.72265625
▁pain 4.71875
▁measurement 5.26953125
▁scale 0.720703125
▁from 4.24609375
▁ 0.552734375
0 0.2890625
▁to 0.24755859375
▁ 0.01361846923828125
1 0.07330322265625
0 0.031219482421875
▁to 3.19921875
▁evaluate 1.4365234375
▁dis 5.95703125
com 0.171875
fort 0.0127716064453125
▁Fe 12.5234375
el 0.9677734375
ings 0.029022216796875
▁during 4.0546875
▁the 0.259765625
▁last 1.0478515625
▁month 1.783203125
. 0.23974609375
<0x0A> 0.447509765625
Am 6.06640625
ong 0.017669677734375
▁all 2.25
▁participants 2.240234375
▁in 3.638671875
▁the 0.1593017578125
▁study 0.51611328125
, 0.04266357421875
▁ 0.85791015625
4 1.8076171875
2 2.482421875
. 1.0908203125
2 2.22265625
% 0.059844970703125
▁suffered 3.857421875
▁from 0.0496826171875
▁de 1.591796875
pression 0.3359375
, 0.88720703125
▁and 1.1484375
▁ 0.1201171875
3 1.474609375
7 2.39453125
% 2.568359375
▁experienced 1.8818359375
▁excess 6.80859375
ive 0.038726806640625
▁anx 0.2225341796875
iety 0.0134429931640625
. 0.395263671875
▁The 1.396484375
▁pl 10.6015625
ur 1.0927734375
ality 0.0013608932495117188
▁of 0.110595703125
▁de 2.48046875
press 0.984375
ive 0.35498046875
▁dis 2.568359375
orders 0.0732421875
▁among 3.06640625
▁patients 1.10546875
▁in 2.77734375
▁the 0.330078125
▁op 0.5751953125
i 0.427978515625
ates 0.01091766357421875
, 8.9296875
▁medical 4.19921875
▁mar 0.044647216796875
iju 0.01467132568359375
ana 0.0003230571746826172
, 0.18896484375
▁and 0.0899658203125
▁mixed 1.6796875
▁OP 11.09375
MM 8.015625
▁groups 0.6142578125
▁number 8.9140625
ed 0.019744873046875
▁ 0.149169921875
5 1.8408203125
7 2.685546875
. 0.50341796875
1 2.50390625
%, 0.1922607421875
▁ 0.005405426025390625
2 2.185546875
2 2.64453125
. 0.1082763671875
3 2.26171875
%, 0.057952880859375
▁and 0.05047607421875
▁ 0.00284576416015625
5 2.046875
1 2.06640625
. 0.16064453125
4 1.962890625
%, 0.1773681640625
▁respectively 0.057159423828125
. 0.273681640625
▁The 1.291015625
▁pl 4.05078125
ur 0.029266357421875
ality 0.0009021759033203125
▁of 0.0250091552734375
▁anx 0.4150390625
iety 0.05279541015625
▁contained 10.84375
▁ 0.216064453125
4 1.123046875
8 2.36328125
. 0.16552734375
4 2.185546875
% 2.013671875
▁among 2.5078125
▁OP 6.515625
▁patients 7.3984375
, 0.28271484375
▁ 0.0694580078125
2 0.943359375
1 2.44921875
. 0.11444091796875
5 2.11328125
% 0.0307159423828125
▁among 0.45751953125
▁MM 0.116943359375
▁patients 0.408447265625
, 0.0163116455078125
▁and 0.01300048828125
▁ 0.0218963623046875
3 1.4267578125
8 1.9033203125
. 0.12939453125
7 2.216796875
% 0.0162811279296875
▁among 0.174072265625
▁OP 2.65234375
MM 0.135498046875
▁participants 2.794921875
. 0.2607421875
▁Pat 5.25
ients 0.01593017578125
▁who 2.017578125
▁took 2.205078125
▁strong 10.3046875
▁op 0.58251953125
i 0.9853515625
ates 0.017181396484375
▁were 1.1201171875
▁t 8.5546875
ended 2.603515625
▁to 0.010162353515625
▁place 10.21875
▁their 2.05859375
▁pain 1.2001953125
▁on 1.9140625
▁a 0.496337890625
▁scale 1.7568359375
▁of 0.378662109375
▁ 0.111328125
9 2.412109375
▁to 2.205078125
▁ 0.0146026611328125
1 0.0058135986328125
0 0.00783538818359375
▁( 2.759765625
Fe 1.7431640625
ing 0.011962890625
old 0.0036182403564453125
▁et 0.0237579345703125
▁al 0.0033931732177734375
., 0.016082763671875
▁ 0.00283050537109375
2 0.00023543834686279297
0 0.00012493133544921875
1 0.0029697418212890625
7 0.0082855224609375
). 0.0154876708984375
▁They 4.41015625
▁were 1.8154296875
▁also 0.90576171875
▁an 9.078125
gu 3.41796875
ished 0.11279296875
▁em 6.21875
otion 0.0278167724609375
ally 0.01023101806640625
▁and 1.0478515625
▁react 7.5546875
ed 0.0241546630859375
▁rad 9.0546875
ically 0.02410888671875
▁neg 4.8203125
atively 0.0254669189453125
▁to 0.181884765625
▁almost 5.38671875
▁all 1.6640625
▁survey 3.619140625
▁questions 0.189697265625
. 0.272705078125
▁Pat 3.80078125
ients 0.005794525146484375
▁who 1.279296875
▁took 1.607421875
▁only 4.3671875
▁MM 0.317138671875
▁or 2.728515625
▁mixed 2.494140625
▁medic 1.5146484375
ations 0.24072265625
▁course 13.75
▁had 2.703125
▁a 1.3837890625
▁significantly 3.033203125
▁more 3.33984375
▁stable 2.46484375
▁emot 0.76708984375
ional 0.00579833984375
▁state 0.6044921875
▁and 1.0849609375
▁cop 6.59765625
ed 0.030487060546875
▁with 0.390869140625
▁pain 0.9150390625
▁more 1.9150390625
▁manage 6.80859375
able 1.8837890625
. 0.27392578125
<0x0A> 0.3037109375
One 4.93359375
▁of 0.1990966796875
▁the 0.0041656494140625
▁major 2.939453125
▁limitations 2.46484375
▁is 3.072265625
▁the 0.48974609375
▁ins 4.6796875
u 0.115478515625
fficient 0.228515625
ly 3.37109375
▁high 3.15625
▁response 3.267578125
▁rate 0.10443115234375
, 2.630859375
▁ 4.69921875
5 1.7548828125
7 2.927734375
% 2.279296875
▁instead 6.27734375
▁of 0.003986358642578125
▁ 0.455322265625
7 1.9443359375
0 0.414794921875
% 1.423828125
▁( 2.3046875
Fe 0.6904296875
ing 0.00519561767578125
old 0.0023174285888671875
▁et 0.01422882080078125
▁al 0.0007886886596679688
., 0.00897979736328125
▁ 0.00218963623046875
2 0.00011706352233886719
0 0.00023674964904785156
1 0.0006456375122070312
7 0.00506591796875
). 0.01323699951171875
▁It 1.7607421875
▁can 3.09375
▁be 0.8076171875
▁fairly 8.6171875
▁expla 8.78125
In 2.189453125
ed 0.005443572998046875
▁by 0.161376953125
▁the 0.33154296875
▁weak 7.171875
▁focus 6.875
▁of 0.70947265625
▁respond 6.05078125
ents 0.07635498046875
▁who 3.3828125
▁have 4.0078125
▁overcome 8.3203125
▁severe 2.21484375
▁pain 0.58056640625
▁sens 7.58203125
ations 0.2059326171875
▁and 0.8359375
▁de 4.73046875
press 0.6533203125
ive 0.131103515625
▁episodes 2.14453125
. 0.51953125
▁It 2.8359375
▁is 0.76953125
▁not 2.666015625
▁clear 3.580078125
▁how 1.9521484375
▁to 3.490234375
▁use 5.265625
▁these 2.80078125
▁statistics 4.06640625
, 3.06640625
▁as 0.677734375
▁they 1.880859375
▁still 5.12890625
▁may 4.76171875
▁be 1.28515625
▁relevant 5.89453125
▁for 1.5517578125
▁the 1.9599609375
▁overall 4.69921875
▁analysis 2.611328125
. 0.8681640625
